Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD
| Autor: | Sean W. Hayes, Daniel S. Berman, John D. Friedman, Ishac Cohen, Rory Hachamovitch |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Male
medicine.medical_specialty Cost-Benefit Analysis medicine.medical_treatment Coronary Artery Disease Single-photon emission computed tomography Revascularization Risk Assessment Cohort Studies Coronary artery disease medicine Humans Myocardial infarction Aged Tomography Emission-Computed Single-Photon medicine.diagnostic_test Proportional hazards model business.industry Middle Aged Prognosis medicine.disease Treatment Outcome Heart Function Tests Exercise Test Female Radiology Cardiology and Cardiovascular Medicine Risk assessment business Emission computed tomography Cohort study |
| Zdroj: | Journal of the American College of Cardiology. 43:200-208 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/j.jacc.2003.07.043 |
| Popis: | ObjectivesWe sought to evaluate the prognostic and cost implications of stress myocardial perfusion single-photon emission computed tomography (SPECT), or MPS, in patients with a high pretest likelihood (>0.85) of coronary artery disease (CAD) with no previous CAD.BackgroundSparse data are available regarding the prognostic performance characteristics of MPS in this patient group.MethodsWe followed up 1,270 consecutive patients with no previous revascularization or myocardial infarction (MI), with a pre–exercise tolerance test (ETT) likelihood of CAD ≥0.85, who underwent exercise or adenosine stress MPS (follow-up 94.4% complete; 2.2 ± 1.2 years; 60 hard events [5.9%, 2.6%/year]). Risk adjustment of survival data was done using Cox proportional hazards analysis. Costs per reclassification of risk were calculated using assumed costs and threshold analyses.ResultsIn patients treated medically after MPS, normal MPS had a low risk of cardiac death and hard events (0.6% and 1.3% per year, respectively). With increasing extent and severity of MPS defects, the risk of both cardiac death and hard events increased significantly (p < 0.05). Cox models indicated that the addition of MPS data resulted in incremental prognostic value over pre-MPS data (chi-square increase 48 to 87, p < 0.0001). Compared with strategies of initial referral to ETT in patients able to exercise, initial referral to MPS appeared to be a more cost-effective strategy. Similarly, compared with a strategy of direct referral to catheterization in patients with a high likelihood of CAD, initial referral to MPS is a cost-saving approach.ConclusionsIn patients with a high likelihood of CAD but without known CAD, stress MPS yields incremental value and achieves risk stratification in a cost-effective manner. The current results support a strategy of initial stress imaging in this patient cohort, as a reasonable alternative to direct referral to catheterization or initial ETT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|